Health status of prevalent cancer cases as measured by mortality dynamics (cancer vs. noncancer): Application to five major cancers sites

被引:12
作者
Colonna, Marc [1 ,2 ]
Grosclaude, Pascale [2 ,3 ]
Bouvier, Anne Marie [2 ,4 ,5 ]
Goungounga, Juste [4 ,5 ]
Jooste, Valerie [2 ,4 ,5 ]
机构
[1] Univ Hosp Grenoble, Isere Canc Registry, Grenoble, France
[2] French Network Canc Registries FRANCIM, Toulouse, France
[3] Claudius Regaud Inst, Tarn Canc Registry, Toulouse, France
[4] Dijon Univ Hosp, Digest Canc Registry Burgundy, Dijon, France
[5] Univ Burgundy Franche Comte, Natl Inst Hlth & Med Res, Unit Epidemiol & Clin Res Digest Canc 1231, Dijon, France
关键词
causes of death; crude probability of death; excess mortality rate; health status; prevalence; FLEXIBLE PARAMETRIC MODELS; RELATIVE SURVIVAL; TRENDS; FRANCE; CURE;
D O I
10.1002/cncr.34413
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Cancer prevalence is heterogeneous because it includes individuals who are undergoing initial treatment and those who are in remission, experiencing relapse, or cured. The proposed statistical approach describes the health status of this group by estimating the probabilities of death among prevalent cases. The application concerns colorectal, lung, breast, and prostate cancers and melanoma in France in 2017. Methods Excess mortality was used to estimate the probabilities of death from cancer and other causes. Results For the studied cancers, most deaths from cancer occurred during the first 5 years after diagnosis. The probability of death from cancer decreased with increasing time since diagnosis except for breast cancer, for which it remained relatively stable. The time beyond which the probability of death from cancer became lower than that from other causes depended on age and cancer site: for colorectal cancer, it was 6 years after diagnosis for women (7 years for men) aged 75-84 and 20 years for women (18 years for men) aged 45-54 years, whereas cancer was the major cause of death for women younger than 75 years whatever the time since diagnosis for breast and for all patients younger than 75 years for lung cancer. In contrast, deaths from other causes were more frequent in all the patients older than 75 years. Apart from breast cancer in women younger than 55 years and lung cancer in women older than 55 years and men older than 65 years, the probability of death from cancer among prevalent cases fell below 1%, with varying times since diagnosis. Conclusions The authors' approach can be used to better describe the burden of cancer by estimating outcomes in prevalent cases.
引用
收藏
页码:3663 / 3673
页数:11
相关论文
共 20 条
[1]   A new approach to estimate time-to-cure from cancer registries data [J].
Boussari, Olayide ;
Romain, Gaelle ;
Remontet, Laurent ;
Bossard, Nadine ;
Mounier, Morgane ;
Bouvier, Anne-Marie ;
Binquet, Christine ;
Colonna, Marc ;
Jooste, Valerie .
CANCER EPIDEMIOLOGY, 2018, 53 :72-80
[2]   Global estimates of cancer prevalence for 27 sites in the adult population in 2008 [J].
Bray, Freddie ;
Ren, Jian-Song ;
Masuyer, Eric ;
Ferlay, Jacques .
INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (05) :1133-1145
[3]   Time trends and short term projections of cancer prevalence in France [J].
Colonna, M. ;
Boussari, O. ;
Cowppli-Bony, A. ;
Delafosse, P. ;
Romain, G. ;
Grosclaude, P. ;
Jooste, V .
CANCER EPIDEMIOLOGY, 2018, 56 :97-105
[4]   Survival of solid cancer patients in France, 1989-2013: a population-based study [J].
Cowppli-Bony, Anne ;
Uhry, Zoe ;
Remontet, Laurent ;
Voirin, Nicolas ;
Guizard, Anne-Valerie ;
Tretarre, Brigitte ;
Bouvier, Anne-Marie ;
Colonna, Marc ;
Bossard, Nadine ;
Woronoff, Anne-Sophie ;
Grosclaude, Pascale .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2017, 26 (06) :461-468
[5]   Long-term survival, prevalence, and cure of cancer: a population-based estimation for 818 902 Italian patients and 26 cancer types [J].
Dal Maso, L. ;
Guzzinati, S. ;
Buzzoni, C. ;
Capocaccia, R. ;
Serraino, D. ;
Caldarella, A. ;
Dei Tos, A. P. ;
Falcini, F. ;
Autelitano, M. ;
Masanotti, G. ;
Ferretti, S. ;
Tisano, F. ;
Tirelli, U. ;
Crocetti, E. ;
De Angelis, R. .
ANNALS OF ONCOLOGY, 2014, 25 (11) :2251-2260
[6]  
Danckert B., 2019, NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic countries
[7]   Cancer incidence and mortality trends in France over 1990-2018 for solid tumors: the sex gap is narrowing [J].
Defossez, G. ;
Uhry, Z. ;
Delafosse, P. ;
Dantony, E. ;
d'Almeida, T. ;
Plouvier, S. ;
Bossard, N. ;
Bouvier, A. M. ;
Molinie, F. ;
Woronoff, A. S. ;
Colonna, M. ;
Grosclaude, P. ;
Remontet, L. ;
Monnereau, A. .
BMC CANCER, 2021, 21 (01)
[8]   Cancer survival statistics for patients and healthcare professionals - a tutorial of real-world data analysis [J].
Eloranta, S. ;
Smedby, K. E. ;
Dickman, P. W. ;
Andersson, T. M. .
JOURNAL OF INTERNAL MEDICINE, 2021, 289 (01) :12-28
[9]   NORDCAN - a Nordic tool for cancer information, planning, quality control and research [J].
Engholm, Gerda ;
Ferlay, Jacques ;
Christensen, Niels ;
Bray, Freddie ;
Gjerstorff, Marianne L. ;
Klint, Asa ;
Kotlum, Joanis E. ;
Olafsdottir, Elinborg ;
Pukkala, Eero ;
Storm, Hans H. .
ACTA ONCOLOGICA, 2010, 49 (05) :725-736
[10]   Prostate cancer incidence and mortality trends in France from 1980 to 2011 [J].
Grosclaude, P. ;
Belot, A. ;
Marliac, L. Daubisse ;
Remontet, L. ;
Leone, N. ;
Bossard, N. ;
Velten, M. .
PROGRES EN UROLOGIE, 2015, 25 (09) :536-542